{'fraction_non_alphanumeric': 0.021040974529346623, 'fraction_numerical': 0.0, 'mean_word_length': 5.277777777777778, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Coinfection with HIV and HCV--epidemiologic, diagnostic, clinical and therapeutic implications].

Because of shared transmission pathways, coinfection with HIV and HCV is common. Besides evidence is accumulating that HIV infection may be a cofactor for heterosexual and perinatal transmission of HCV infection. The increasing survival of patients on HAART has emphasized the importance of treating liver disease because co-infected patients are now often dying of their liver disease. There is a common opinion that HIV infection causes rapid and more severe course of HCV-related liver disease. The impact of HCV infection on HIV disease progression is controversial. The treatment of patients co-infected with HIV and HCV is difficult. Therapeutic options depend on immunological status of patients and severity of liver disease. In addition hepatotoxicity and drug interactions should be considered.